Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause
- Conditions
- Genitourinary Syndrome of Menopause
- Registration Number
- NCT03506594
- Lead Sponsor
- Centro de Atenção ao Assoalho Pélvico
- Brief Summary
The study is conducted in women at the menopause with a clinical diagnosis of Genitourinary Syndrome, which presents symptoms in of vulvovaginal atrophy and tract urinary and were treated with radiofrequency non ablative technique for capacitive transfer in intra-vaginal. All participants were evaluated by a physical therapist and did the exam of PH vaginal, cell maturation index and questionnaires. The participants made five sessions of Radio Frequency (RF) with an interval of seven days between them. The application of RF was performed by physical therapist trained in the technique of radio frequency through the Capenergie brand device with capacitive transfer method using non-ablative handle with active electrode intra-vaginal and coupling electrode placed on the participant's back. For application, the participants were in gynecological position. The session had an average duration above 20 minutes. The temperature was measured by an infrared thermometer when it reached 41graus radiofrequency was maintained for 2 minutes in the anterior wall and 2 minutes more in the posterior wall of vagina.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 58
- will be women in menopause until 65 years of age with clinical complaints of Genitourinary Syndrome of Menopause and who agree to voluntarily participate in the research.
- will be excluded from the study participants with limited understanding, with neurological degenerative chronic diseases, sensory deficit in the genital region, users of pacemaker and intrauterine device of cooper and women under hormone therapy under six months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in Cell maturation index Each 3 months pos treatment, until one year % cells parabasal, % intermediate cells and superficial cells
Change in Vaginal PH Each 3 months pos treatment, until one year During the fertile years of life, the vaginal pH ranges from 3.5 to 4.5. At menopause, vaginal Ph increases to above 4.5. The higher the vaginal Ph, the greater the degree of atrophy
- Secondary Outcome Measures
Name Time Method Female Genital Self-image Scale one week, one month, three months, six months, nine months and one year Questionnaire of quality of life specified urinary incontinence one week, one month, three months, six months, nine months and one year The ICIQ-SF
Numeric Visual Scale one week, one month, three months, six months, nine months and one year Will be evaluated vaginal dryness, pain during intercourse, vaginal laxity, burning sensation and itching, on a scale of 0 to 10, being 0 asymptomatic and 10 the maximum of symptoms
Female Sexual Function Index one week, one month, three months, six months, nine months and one year FSFI
Trial Locations
- Locations (1)
Centro de Atenção ao Assoalho Pelvico
🇧🇷Salvador, Ba, Brazil
Centro de Atenção ao Assoalho Pelvico🇧🇷Salvador, Ba, Brazil